Lisata Therapeutics (LSTA) Operating Income (2016 - 2025)
Historic Operating Income for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to -$4.4 million.
- Lisata Therapeutics' Operating Income rose 1727.89% to -$4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.1 million, marking a year-over-year increase of 1450.71%. This contributed to the annual value of -$22.4 million for FY2024, which is 1283.26% up from last year.
- Lisata Therapeutics' Operating Income amounted to -$4.4 million in Q3 2025, which was up 1727.89% from -$4.9 million recorded in Q2 2025.
- In the past 5 years, Lisata Therapeutics' Operating Income registered a high of -$4.4 million during Q3 2025, and its lowest value of -$6.9 million during Q2 2023.
- Over the past 3 years, Lisata Therapeutics' median Operating Income value was -$5.8 million (recorded in 2025), while the average stood at -$5.7 million.
- Within the past 5 years, the most significant YoY rise in Lisata Therapeutics' Operating Income was 1966.55% (2024), while the steepest drop was 355.06% (2024).
- Lisata Therapeutics' Operating Income (Quarter) stood at -$6.0 million in 2023, then rose by 17.86% to -$4.9 million in 2024, then rose by 10.81% to -$4.4 million in 2025.
- Its Operating Income stands at -$4.4 million for Q3 2025, versus -$4.9 million for Q2 2025 and -$5.8 million for Q1 2025.